Skip to main content
OpenTrials
Completed

NCT Number: NCT05613712

Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine

Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Inflammatory Disease Ankylosis Arthritis Arthritis, Psoriatic Arthritis, Rheumatoid Autoimmune Diseases Axial Spondyloarthritis Behavior Bone Diseases Connective Tissue Diseases Health Behavior Immune System Diseases Joint Diseases Musculoskeletal Diseases Patient Acceptance of Health Care Patient Compliance Psoriasis Rheumatic Diseases Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases Spinal Diseases Spondylarthritis Spondylarthropathies Spondylitis Spondylitis, Ankylosing Treatment Adherence and Compliance

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Grenoble Alpes

Grenoble, 38043, France

About this study

In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient cohort :
  • men and women over 18 years of age
  • Informed volunteers who have consented to participate in the study
  • have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis
  • have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department
  • Cohort of referring physicians :
  • volunteers who received informed information and consented to participate in the study
  • be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes

Exclusion criteria

  • Patient cohort :
  • psychiatric pathologies or history of behavioural disorders
  • persons referred to in articles L1121-5 to L1121-8 of the Public Health Code
  • persons under guardianship or curatorship
  • not affiliated to the social security system
  • minors
  • Refusal to participate by the patient and/or unreturned questionnaire
  • Cohort of referring physicians:
  • the physician is no longer the patient's referring physician
  • refusal of the doctor to participate and/or questionnaire not returned

Treatment and study plan

Patients

Other

Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up

Referring physician

Other

Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes

Primary outcomes

  1. Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes, through questionnaires

    Time frame: 1 day

    Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes

Secondary outcomes

  1. Elements limiting the good ambulatory follow-up, according to the patients

    Time frame: 1 day

    Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up

  2. Elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes, according to the patients

    Time frame: 1 day

    Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes

Sponsors and collaborators

Lead sponsor

University Hospital, Grenoble

Other

Registry information

Acronym: SCORIC-A

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Nov 14, 2022
Registry last updated
Dec 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.